Abcodia is a specialist company that focuses on biomarkers for cancer screening. Its aim is to discover and validate biomarkers that can be used for the early detection of cancer. Early detection provides more treatment options and has been shown to improve survival rates. Working in collaboration with academics, technology partners and commercial diagnostic partners, Abcodia aims to dramatically improve the way cancer is detected and managed.

Abcodia is a specialist company that focuses on biomarkers for cancer screening. Its aim is to discover and validate biomarkers that can be used for the early detection of cancer. Early detection provides more treatment options and has been shown to improve survival rates. Working in collaboration with academics, technology partners and commercial diagnostic partners, Abcodia aims to dramatically improve the way cancer is detected and managed.